Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Handen

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Disability and Health Journal|March 8, 2022
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndromeSigan L Hartley, Victoria Fleming, Brianna Piro-Gambetti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 8, 2020
Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case reportElijah Mak, Anastasia Bickerton, Concepcion Padilla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2023
Timing of Alzheimer's Disease by Intellectual Disability Level in Down SyndromeSigan L Hartley, Victoria Fleming, Emily K Schworer, et al.
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Neurobiology of Aging|August 14, 2022
Amyloid- β and tau deposition influences cognitive and functional decline in Down syndromeMonika Grigorova, Elijah Mak, Stephanie S G Brown, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Journal of Developmental and Physical Disabilities|June 5, 2013
Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental DisordersBenjamin L Handen, Cynthia R Johnson, Eric M Butter, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Disability and Health Journal|March 8, 2022
Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndromeSigan L Hartley, Victoria Fleming, Brianna Piro-Gambetti, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 8, 2020
Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case reportElijah Mak, Anastasia Bickerton, Concepcion Padilla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 13, 2024
The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndromeAnna H Boerwinkle, Julie K Wisch, Benjamin L Handen, et al.
Journal of Alzheimer'S Disease : JAD|July 24, 2023
Timing of Alzheimer's Disease by Intellectual Disability Level in Down SyndromeSigan L Hartley, Victoria Fleming, Emily K Schworer, et al.
Neurobiology of Aging|October 26, 2018
Comparison of longitudinal Aβ in nondemented elderly and Down syndromeDana L Tudorascu, Stewart J Anderson, Davneet S Minhas, et al.
Neurobiology of Aging|August 14, 2022
Amyloid- β and tau deposition influences cognitive and functional decline in Down syndromeMonika Grigorova, Elijah Mak, Stephanie S G Brown, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 29, 2023
Characterizing the emergence of amyloid and tau burden in Down syndromeMatthew D Zammit, Tobey J Betthauser, Andrew K McVea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2025
Genome-wide association of tau neuroimaging and plasma biomarkers in adults with Down syndromeKang-Hsien Fan, Ruyu Shi, Asma Naseer Cheema, et al.
Journal of Developmental and Physical Disabilities|June 5, 2013
Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental DisordersBenjamin L Handen, Cynthia R Johnson, Eric M Butter, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 11, 2020
The Alzheimer's Biomarker Consortium-Down Syndrome: Rationale and methodologyBenjamin L Handen, Ira T Lott, Bradley T Christian, et al.
Pageof 12